Texas will ban smokeable hemp cannabis on March 31. Here’s what you need to know.
Texas hemp ban compliance is critical as the state bans smokeable hemp cannabis starting March 31, 2024. This affects patient access to inhaled hemp products and requires clinical adjustments. Clinicians must guide patients on legal alternatives and…
Livermore Falls Advances Cannabis Ordinance to Voters – Sun Journal
Local cannabis ordinances patient access is a critical issue in Livermore Falls as the town advances a cannabis ordinance to voters. These ordinances influence how patients obtain legal cannabis products and navigate municipal regulations. Understanding…
Understanding Michigan’s New Wholesale Cannabis Tax Guidance
Michigan wholesale cannabis tax guidance introduces new regulatory challenges affecting cannabis pricing and patient access. These changes may impact treatment adherence and continuity. Healthcare providers should monitor these developments closely.
Dabstract and Trulieve Collaborate on Maryland Cannabis Product Launch
Maryland medical cannabis standardization is advancing through a new partnership between Dabstract and Trulieve. This collaboration aims to enhance product quality and consistency in the Maryland market. Patients and clinicians should monitor therapeutic…
Mississippi Medical Cannabis Bills Advance Toward Governor’s Approval
Mississippi medical cannabis program legislation marks a significant step in expanding patient access in the Southeast. This legislation aims to establish a regulated program for qualifying patients. Clinicians should prepare for increased patient…
Cannabis Clinical Relevance March 24 2026 Digest
The cannabis clinical relevance March 24 2026 digest presents 40 carefully curated items highlighting recent research and regulatory updates. Clinicians will find valuable insights into cannabinoid compounds and patient access. This digest supports…
Medical Cannabis Program Challenges in 2026 Launch
The medical cannabis program challenges in Alabama are critical as the state prepares for its 2026 launch. Clinicians must understand these challenges to support patient access and regulatory compliance. This digest highlights key issues in medical…
The role of cannabis-based medicinal products (CBMPs) in managing osteoarthritis symptoms: a scoping review of current evidence and future directions.
This review critically evaluates cbd topical pain safety in managing osteoarthritis symptoms. It highlights clinical evidence supporting cannabis-based medicinal products for symptom relief. The review also discusses future directions for research and…
Albert Lea City Council Approves Two Cannabis Registrations
Municipal cannabis approvals are critical for patient access to legal cannabis products. Albert Lea City Council recently approved two cannabis registrations, marking an important local regulatory step. These approvals ensure patients can obtain…
Mississippi Medical Cannabis Bills Head to Governor’s Desk – WDAM
Mississippi medical cannabis implementation is progressing with bills now awaiting the governor's signature. This legislation will affect patient access and clinical use. Healthcare providers should monitor qualifying conditions and regulations closely.